Posted: March 2, 2020
Applications due May 21, 2020; November 19. 2020; May 20, 2021; November 18, 2021
This Funding Opportunity Announcement (FOA), entitled "Toward Translation of Cancer Nanotechnology Interventions (TTNCI)" is to enable the translation of nanotechnology-based cancer interventions relying on next-generation nanoparticle formulations and/or nano-devices. The TTNCI initiative encourages applications for advanced pre-clinical research, supporting translation of nanotechnology-based cancer diagnostics and therapeutics. The "Toward Translation of Nanotechnology Cancer Interventions" (TTNCI) awards are designed to mature experimental nanomedicines relying on "next-generation" nanoparticles and nano-devices which demonstrate strong potential to improve treatment effectiveness and/or tackle cancers that currently have a very limited arsenal of approved therapies or diagnostic strategies. TTNCI awards are expected to enable further development of proposed nanotechnology-based interventions to the stage in which they could continue on a developmental path towards the NCI Experimental Therapeutics (NExT) and other NCI translational programs.
Office of Grants and Contracts
Address
107 Ag Administration BuildingUniversity Park, PA 16802
- Email L-AG-contgrts@lists.psu.edu
- Office 814-865-5419
Office of Grants and Contracts
Address
107 Ag Administration BuildingUniversity Park, PA 16802
- Email L-AG-contgrts@lists.psu.edu
- Office 814-865-5419